Verrica Pharmaceuticals Inc. — Director's Dealing 2021

Jun 14, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Verrica Pharmaceuticals Inc. (VRCA)
CIK: 0001660334
Period of Report: 2021-06-10

Reporting Person: Ballaron Craig (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-10	Stock Option (right to buy)	$10.56	A	5834	Acquired	2031-06-09	Common Stock (5834)	Direct

Footnotes

F1: The shares underlying this option shall vest and become exercisable in 12 equal monthly installments beginning on July 10, 2021 and, in any event, will be fully vested on the date of the next annual meeting of stockholders, subject to continued service as a director though the applicable vesting date.